Publications by authors named "Eric Messina"

Claim this Profile
C
Characterization of large volume subcutaneous injections using computed tomography imaging and simultaneous pressure measurements.
Mona Purcell, Sahab Babaee, Michael Galluppi, John Cline, Guangli Hu, Eric Messina

Front Drug Deliv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
Ednan K Bajwa, Dawn Cislak, Amit Kumar, Dan Li, Eric J Messina

Int J Chron Obstruct Pulmon Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH).
Ednan K Bajwa, Dawn Cislak, John Palcza, Hwa-Ping Feng, Eric J Messina

Respir Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust arterial spin labeling MRI measurement of pharmacologically induced perfusion change in rat kidneys.
Fuqiang Zhao, Xiaoyan Zhou, Eric Messina, Lufei Hu, Marie A Holahan

NMR Biomed· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of total liver blood flow in intact anesthetized rats using ultrasound imaging.
Christopher R Gibson, Alexa Gleason, Eric Messina

Pharmacol Res Perspect· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs.
Gong Zhao, Erin Walsh, John C Shryock, Eric Messina, Yuzhi Wu

J Cardiovasc Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regadenoson, a novel pharmacologic stress agent for use in myocardial perfusion imaging, does not have a direct effect on the QT interval in conscious dogs.
Gong Zhao, Sabrina Serpllion, John Shryock, Eric Messina, Xiaobin Xu

J Cardiovasc Pharmacol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.
Gong Zhao, Eric Messina, Xiaobin Xu, Manuel Ochoa, Hai-Ling Sun

J Cardiovasc Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
Gong Zhao, Eric Messina, Xiaobin Xu, Manuel Ochoa, Sobrina Serpillon

Eur J Pharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
gp91phox-containing NAD(P)H oxidase mediates attenuation of nitric oxide-dependent control of myocardial oxygen consumption by ANG II.
Shintaro Kinugawa, Juhua Zhang, Eric Messina, Erin Walsh, Harer Huang

Am J Physiol Heart Circ Physiol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats.
Alexandra Adler, Eric Messina, Ben Sherman, Zipping Wang, Harer Huang

Am J Physiol Heart Circ Physiol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis